ID   CB1R_FELCA     STANDARD;      PRT;   472 AA.
AC   O02777;
DT   15-JUL-1998 (Rel. 36, Created)
DT   15-JUL-1998 (Rel. 36, Last sequence update)
DT   16-OCT-2001 (Rel. 40, Last annotation update)
DE   Cannabinoid receptor 1 (CB1) (CB-R).
GN   CNR1.
OS   Felis silvestris catus (Cat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Carnivora; Fissipedia; Felidae; Felis.
OX   NCBI_TaxID=9685;
RN   [1]
RP   SEQUENCE FROM N.A.
RA   Gebremedhin D., Lange A.R., Aebly M.R., Campbell W.B., Hillard C.J.,
RA   Harder D.R.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Involved in cannabinoid-induced CNS effects. Acts by
CC       inhibiting adenylate cyclase. Could be a receptor for anandamide.
CC       Inhibits L-type Ca(2+) channel current.
CC   -!- SUBCELLULAR LOCATION: Integral membrane protein.
CC   -!- TISSUE SPECIFICITY: EXPRESSED IN CEREBRAL ARTERIAL MUSCLE CELLS.
CC   -!- SIMILARITY: BELONGS TO FAMILY 1 OF G-PROTEIN COUPLED RECEPTORS.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; U94342; AAB53440.1; -.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
KW   G-protein coupled receptor; Transmembrane; Glycoprotein.
FT   DOMAIN        1    116       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    117    142       1 (POTENTIAL).
FT   DOMAIN      143    154       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM    155    175       2 (POTENTIAL).
FT   DOMAIN      176    187       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    188    212       3 (POTENTIAL).
FT   DOMAIN      213    232       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM    233    255       4 (POTENTIAL).
FT   DOMAIN      256    273       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    274    299       5 (POTENTIAL).
FT   DOMAIN      300    344       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM    345    365       6 (POTENTIAL).
FT   DOMAIN      366    377       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    378    399       7 (POTENTIAL).
FT   DOMAIN      400    472       CYTOPLASMIC (POTENTIAL).
FT   CARBOHYD     77     77       N-LINKED (GLCNAC...) (POTENTIAL).
FT   CARBOHYD     83     83       N-LINKED (GLCNAC...) (POTENTIAL).
SQ   SEQUENCE   472 AA;  52887 MW;  A2774DBF8F2DAF34 CRC64;
     MKSILDGLAD TTFRTITTDL LYVGSNDIQY EDIKGDMASK LGYFPQKFPL TSFRGSPFQE
     KMTAGDNSQL VPADQVNITE FYNKSLSSYK ENEENIQCGE NFMDMECFMI LNPSQQLAIA
     VLSLTLGTFT VLENLLVLCV ILHSRSLRCR PSYHFIGSLA VADLLGSVIF VYSFVDFHVF
     HRKDSPNVFL FKLGGVTASF TASVGSLFLT AIDRYISIHR PLAYKKIVTR PKAVVAFCLM
     WTIAIVIAVL PLLGWNCKKL QSVCSDIFPL IDETYLMFWI GVTSVLLLFI VYAYMYILWK
     AHIHAVRMIQ RGTQKSIIIH TSEDGKVQVT RPDQARMDIR LAKTLVLILV VLIICWGPLL
     AIMVYDVFGK MNKLIKTVFA FCSMLCLLNS TVNPIIYALR SKDLRHAFRS MFPSCEGTAQ
     PLDNSMGDSD CLHKHANNTA NVHRAAENCI KNTVQIAKVT ISVSTNTSAK AL
//